Panel 3. Bridging the Divide With FDA, ECRI, and Industry Alignment

This panel brings together representatives from the FDA, industry, and ECRI to discuss how regulatory approval and coverage pathways can be better aligned to accelerate patient access. Panelists will explore practical approaches to aligning evidence expectations across the product lifecycle, reducing uncertainty for stakeholders, and advancing patient-centered access. Discussion will include opportunities to reduce duplicative evidence requirements and improve predictability in regulatory and coverage pathways.